Clinical Trial On Children
- All
- News
- Videos
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Instagram Denies Addiction Claims In Landmark US Trial
Instagram CEO Adam Mosseri on Wednesday rejected the notion that users could be clinically addicted to social media, as he testified in a landmark California trial over whether his company knowingly hooked children on its platform for profit.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
No Scientific Body Suggests Kids' Vaccination For School Opening: Centre
Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Covaxin Trial On Children Begins At AIIMS Patna: Report
Prasar Bharati today announced that India has begun the clinical trial of Bharat Biotech's Covaxin on children. The testing is being done at the AIIMS Patna, it said.
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Instagram Denies Addiction Claims In Landmark US Trial
Instagram CEO Adam Mosseri on Wednesday rejected the notion that users could be clinically addicted to social media, as he testified in a landmark California trial over whether his company knowingly hooked children on its platform for profit.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
No Scientific Body Suggests Kids' Vaccination For School Opening: Centre
Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Covaxin Trial On Children Begins At AIIMS Patna: Report
Prasar Bharati today announced that India has begun the clinical trial of Bharat Biotech's Covaxin on children. The testing is being done at the AIIMS Patna, it said.
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
